Mortality of hemodialysis patients is associated with their clinical situation at the start of treatment

被引:13
作者
de Arriba, Gabriel [1 ,2 ,9 ]
Avila, Gonzalo Gutierrez [3 ,9 ]
Guinea, Marta Torres [4 ,9 ]
Alia, Inmaculada Moreno [3 ,9 ]
Herruzo, Jose Antonio [5 ,9 ]
Ruiz, Begona Rincon [6 ,9 ]
Tejeiro, Rafael Diaz [4 ,9 ]
Rubio, Maria Esperanza Lopez [7 ,9 ]
Poyatos, Carmen Vozmediano [8 ,9 ]
Roldan, Carmina Gomez [7 ,9 ]
机构
[1] Hosp Univ Guadalajara, Guadalajara, Spain
[2] Univ Alcala, Dept Med & Especialidades Med, Madrid, Spain
[3] Junta Comunidades Castilla La Mancha, Consejeria Sanidad, Toledo, Spain
[4] Hosp Virgen Salud Toledo, Toledo, Spain
[5] Ctr Dialisis Asyter, Toledo, Spain
[6] Hosp Virgen Luz Cuenca, Cuenca, Spain
[7] Hosp Gen Univ Albacete, Albacete, Spain
[8] Hosp Gen Univ Ciudad Real, Ciudad Real, Spain
[9] Registro Enfermos Renales Castilla La Mancha RERC, Valencia, Spain
来源
NEFROLOGIA | 2021年 / 41卷 / 04期
关键词
Hemodialysis; Mortality; Albumin; Vascular access; ALL-CAUSE MORTALITY; SURVIVAL;
D O I
10.1016/j.nefro.2020.11.006
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Previous reports have shown very high mortality among hemodialyisis patients. Our goal was to analyze the mortality of patients in the Renal Registry of Patients who remained exclusively on hemodialysis treatment. Methods: The cohort of patients who started treatment in the community of Castilla-La Mancha between 2010 and 2012 and remained on hemodialysis treatment was analysed until the end of 2017. Age, sex, primary kidney disease, vascular access, hemoglobin, Charlson index and serum albumin were included. Results: Mortality rate was 63,4% after 5 years and 76% at the end of the study, with no difference between males and females, and was linked to an older age, urgent onset or in those with acute deterioration of chronic kidney disease, the use of catheters or albumin less than 3.5 g/dl. Conclusions: Mortality in patients who remain on hemodialysis is very high and is associated with non-modifiable factors such as age but also others that we can prevent or treat such as type of vascular access or nutrition status at the beginning of treatment. (C) 2021 Sociedad Espanola de Nefrologia. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:461 / 466
页数:6
相关论文
共 20 条
[1]   Lower serum uric acid level predicts mortality in dialysis patients [J].
Bae, Eunjin ;
Cho, Hyun-Jeong ;
Shin, Nara ;
Kim, Sun Moon ;
Yang, Seung Hee ;
Kim, Dong Ki ;
Kim, Yong-Lim ;
Kang, Shin-Wook ;
Yang, Chul Woo ;
Kim, Nam Ho ;
Kim, Yon Su ;
Lee, Hajeong .
MEDICINE, 2016, 95 (24)
[2]   During the pre-dialysis stage of chronic kidney disease, which treatment is associated with better survival in dialysis? [J].
Caravaca, Francisco ;
Alvarado, Raul ;
Garcia-Pino, Guadalupe ;
Martinez-Gallardo, Rocio ;
Luna, Enrique .
NEFROLOGIA, 2014, 34 (04) :469-476
[3]   An association between time-varying serum albumin level and the mortality rate in maintenance haemodialysis patients: a five-year clinical cohort study [J].
Chen, Jin-Bor ;
Cheng, Ben-Chung ;
Yang, Cheng-Hong ;
Hua, Moi-Sin .
BMC NEPHROLOGY, 2016, 17
[4]   Importance of Simultaneous Evaluation of Multiple Risk Factors for Hemodialysis Patients' Mortality and Development of a Novel Index: Dialysis Outcomes and Practice Patterns Study [J].
Kanda, Eiichiro ;
Bieber, Brian A. ;
Pisoni, Ronald L. ;
Robinson, Bruce M. ;
Fuller, Douglas S. .
PLOS ONE, 2015, 10 (06)
[5]   The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary [J].
Kramer, Anneke ;
Pippias, Maria ;
Noordzij, Marlies ;
Stel, Vianda S. ;
Andrusev, Anton M. ;
Aparicio-Madre, Manuel I. ;
Arribas Monzon, Federico E. ;
Asberg, Anders ;
Barbullushi, Myftar ;
Beltran, Palma ;
Bonthuis, Marjolein ;
Caskey, Fergus J. ;
Castro de la Nuez, Pablo ;
Cernevskis, Harijs ;
De Meester, Johan ;
Finne, Patrik ;
Golan, Eliezer ;
Heaf, James G. ;
Hemmelder, Marc H. ;
Ioannou, Kyriakos ;
Kantaria, Nino ;
Komissarov, Kirill ;
Korejwo, Grzegorz ;
Kramar, Reinhard ;
Lassalle, Mathilde ;
Lopot, Frantisek ;
Macario, Fernando ;
Mackinnon, Bruce ;
Palsson, Runolfur ;
Pechter, Ulle ;
Pinera, Vicente C. ;
de Pablos, Carmen Santiuste ;
Segarra-Medrano, Alfons ;
Seyahi, Nurhan ;
Roblero, Maria F. Slon ;
Stojceva-Taneva, Olivera ;
Vazelov, Evgueniy ;
Winzeler, Rebecca ;
Ziginskiene, Edita ;
Massy, Ziad ;
Jager, Kitty J. .
CLINICAL KIDNEY JOURNAL, 2019, 12 (05) :702-720
[6]   Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis [J].
Ladhani, Maleeka ;
Craig, Jonathan C. ;
Irving, Michelle ;
Clayton, Philip A. ;
Wong, Germaine .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (03) :439-449
[7]   Risk factors for mortality in patients undergoing hemodialysis: A systematic review and meta-analysis [J].
Ma, Lijie ;
Zhao, Sumei .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 238 :151-158
[8]   ESHOL study reanalysis: All-cause mortality considered by competing risks and time-dependent covariates for renal transplantation [J].
Maduell, Francisco ;
Moreso, Francesc ;
Mora-Macia, Josep ;
Pons, Mercedes ;
Ramose, Rosa ;
Carreras, Jordi ;
Soler, Jordi ;
Torres, Ferran .
NEFROLOGIA, 2016, 36 (02) :156-163
[9]   Initial Glomerular Filtration Rate and Survival in Hemodialysis. The role of permanent vascular access [J].
Marinovich, Sergio ;
Perez-Loredo, Jaime ;
Lavorato, Carlos ;
Rosa-Diez, Guillermo ;
Bisigniano, Liliana ;
Fernandez, Victor ;
Hansen-Krogh, Daniela .
NEFROLOGIA, 2014, 34 (01) :76-87
[10]   Medication adherence in randomized controlled trials evaluating cardiovascular or mortality outcomes in dialysis patients: A systematic review [J].
Murali, Karumathil M. ;
Mullan, Judy ;
Chen, Jenny H. C. ;
Roodenrys, Steven ;
Lonergan, Maureen .
BMC NEPHROLOGY, 2017, 18 :1-11